Saint Roch Veterinary LLC, Announces Breakthrough in Canine Dental Health With Revolutionary Periodontal Disease Treatment

Saint Roch Veterinary, LLC, a wholly owned division of Topikos Scientific, Inc., is proud to unveil GingiGuard™, a novel, patented compound that will revolutionize canine dental care. This advanced solution is the first of its kind to address the root causes of periodontal biofilm disease---without systemic effects---by reducing the population of harmful bacteria while restoring a healthy and balanced oral microbiome. A single topical treatment with GingiGuard™ gel in the subgingival sulcus after standard scaling, cleaning and polishing retards plaque growth for four weeks or more, while the dogs’ gingiva appear restored to normal position and appearance and bad breath disappears. Saint Roch is actively seeking joint venture partners for market development.

While periodontal disease affects over 80% of dogs by age three, innovative GingiGuard™ offers hope for long-term, sustainable solutions to a condition that, untreated, leads to tooth loss and systemic inflammatory complications.

Traditional treatments cause systemic symptoms with indiscriminate killing of oral bacteria. GingiGuard™ selectively disrupts dysbiosis by harnessing the advanced technology of its patents-issued, NME (New Molecular Entity.) It supports long-lasting oral health through the balanced growth of beneficial commensal bacteria and effective reduction in harmful biofilm pathogens.

In a field trial of over 140 privately-owned dogs of wide-ranging ages and breeds, conducted by Dr. Kevin Cawood, DVM, and Dr. Mike Bechill, PhD, at Saint Roch, dogs treated with GingiGuard™ and standard oral cleaning, were essentially free of gingivitis and periodontal disease symptoms and findings four weeks following a single application, demonstrating remarkable effectiveness in reducing inflammation, eliminating “doggie breath,” suppressing regrowth of pathogenic bacteria, and promoting oral health. Over the following four months, with no more treatments, plaque slowly returned followed by varying degrees of gingivitis for different breeds, ages & diets. This far exceeded expectations for plaque return, known normally to recur within hours to days following standard Veterinary cleaning. Trial protocol included both pre and posttreatment NGS (next-generation sequencing) of the gingival biome as well as testimony from owners and post operative veterinarian inspections. NGS changes were correlated to clinical findings and owners’ observations. GingiGuard™ also underwent and passed clinical safety laboratory trials with standard Beagle dogs.

“GingiGuard represents a significant leap forward in how we approach oral health for our family’s pets,” said Kevin Cawood, DVM and President of Saint Roch Veterinary LLC, “This is not just another treat or chew, it is a science driven solution that promotes a healthy microbial balance of the oral biome, which is essential for long-term canine health. Learn more about this innovative solution at https://saintroch.vet/gingiguard/.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250126193481/en/